Join Growin Stock Community!

Autonomix medical, inc. common stockAMIX.US Overview

US StockHealthcare
(No presentation for AMIX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

AMIX AI Insights

AMIX Overall Performance

AMIX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

AMIX Recent Performance

-8.89%

Autonomix medical, inc. common stock

0.05%

Avg of Sector

-0.31%

S&P500

AMIX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

AMIX Key Information

AMIX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

AMIX Profile

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Price of AMIX

AMIX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

AMIX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.35
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
0.73
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.35
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
0.73
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is AMIX's latest earnings report released?

    The most recent financial report for Autonomix medical, inc. common stock (AMIX) covers the period of 2026Q3 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating AMIX's short-term business performance and financial health. For the latest updates on AMIX's earnings releases, visit this page regularly.

  • How much cash does AMIX have?

    At the end of the period, Autonomix medical, inc. common stock (AMIX) held Total Cash and Cash Equivalents of 9.93M, accounting for 0.97 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is AMIX's EPS continuing to grow?

    According to the past four quarterly reports, Autonomix medical, inc. common stock (AMIX)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.36. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of AMIX?

    Autonomix medical, inc. common stock (AMIX)'s Free Cash Flow (FCF) for the period is -2.98M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 29.05% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of AMIX?

    The latest valuation data shows Autonomix medical, inc. common stock (AMIX) has a Price-To-Earnings (PE) ratio of -0.26 and a Price/Earnings-To-Growth (PEG) ratio of 0.01. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.